Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC).
Ana M. Molina
No relevant relationships to disclose
Darren Richard Feldman
No relevant relationships to disclose
Michelle S. Ginsberg
No relevant relationships to disclose
Patricia Fischer
No relevant relationships to disclose
Michael J. Trinos
No relevant relationships to disclose
Sujata Patil
No relevant relationships to disclose
Robert John Motzer
No relevant relationships to disclose